DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Vivas S, Ruiz de Morales JM, Ramos F et al.
Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.
The New England journal of medicine 2006;
354: 2514-2515
DOI: 10.1056/NEJMc053129.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.